SLAB - Silicon Laboratories Inc.
NASDAQ
->
Technology
->
Semiconductors
Austin,
United States
Type: Equity
SLAB price evolution
SLAB
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $240.83 | $191.49 | $227.5 | |
| Short term investments | $98.34 | $141.2 | $211.72 | |
| Net receivables | $48.88 | $41.21 | $32.62 | $29.3 |
| Inventory | $139.49 | $166.08 | $198.21 | $194.29 |
| Total current assets | $614.14 | $600.05 | $646.12 | $737.93 |
| Long term investments | ||||
| Property, plant & equipment | $135.32 | $139.4 | $142.16 | $145.89 |
| Goodwill & intangible assets | $423.76 | $429.84 | $435.92 | |
| Total noncurrent assets | $649.94 | $698.03 | $705.13 | |
| Total investments | $98.34 | $141.2 | $211.72 | |
| Total assets | $1249.24 | $1249.99 | $1344.15 | $1443.06 |
| Current liabilities | ||||
| Accounts payable | $44.65 | $39.3 | $44.58 | $57.5 |
| Deferred revenue | $3.32 | $3.92 | $2.12 | |
| Short long term debt | $45 | |||
| Total current liabilities | $118.31 | $100.11 | $111.36 | $163.57 |
| Long term debt | ||||
| Total noncurrent liabilities | $56.84 | $67.23 | $70.8 | |
| Total debt | $45 | |||
| Total liabilities | $167.86 | $156.96 | $178.59 | $234.37 |
| Shareholders' equity | ||||
| Retained earnings | $1025.54 | $1054.05 | $1136.2 | $1192.73 |
| Other shareholder equity | $0.27 | -$0.25 | -$0.48 | -$1.02 |
| Total shareholder equity | $1093.03 | $1165.56 | $1208.68 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $227.5 | $499.92 | $1074.62 | $202.72 |
| Short term investments | $211.72 | $692.02 | $964.58 | $521.96 |
| Net receivables | $29.3 | $71.44 | $98.31 | $95.17 |
| Inventory | $194.29 | $100.42 | $49.31 | $66.66 |
| Total current assets | $737.93 | $1461.36 | $2238.57 | $975.82 |
| Long term investments | ||||
| Property, plant & equipment | $145.89 | $176.73 | $146.52 | $139.44 |
| Goodwill & intangible assets | $435.92 | $461.3 | $495.37 | $798.02 |
| Total noncurrent assets | $705.13 | $708.07 | $719.72 | $1017.67 |
| Total investments | $211.72 | $692.02 | $964.58 | $521.96 |
| Total assets | $1443.06 | $2169.43 | $2958.3 | $1993.49 |
| Current liabilities | ||||
| Accounts payable | $57.5 | $89.86 | $47.33 | $54.95 |
| Deferred revenue | $2.12 | $6.78 | $13.85 | $12.99 |
| Short long term debt | $45 | $450.6 | $134.48 | |
| Total current liabilities | $163.57 | $185.78 | $668.83 | $284.5 |
| Long term debt | $529.57 | $428.94 | ||
| Total noncurrent liabilities | $70.8 | $578.64 | $77.04 | $509.15 |
| Total debt | $45 | $529.57 | $450.6 | $563.42 |
| Total liabilities | $234.37 | $764.42 | $745.87 | $793.65 |
| Shareholders' equity | ||||
| Retained earnings | $1192.73 | $1415.69 | $2214.84 | $993.66 |
| Other shareholder equity | -$1.02 | -$10.69 | -$2.42 | $1.81 |
| Total shareholder equity | $1208.68 | $1405.01 | $2212.42 | $1199.84 |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $166.4 | $145.37 | $106.38 | $86.84 |
| Cost of revenue | $68.78 | $51.31 | $42.92 | |
| Gross Profit | $90.31 | $76.58 | $55.07 | $43.93 |
| Operating activities | ||||
| Research & development | $85.91 | $80.65 | $83.4 | |
| Selling, general & administrative | $38.7 | $33.55 | $33.63 | |
| Total operating expenses | $120.02 | $124.6 | $114.2 | $117.04 |
| Operating income | -$48.02 | -$59.13 | -$73.11 | |
| Income from continuing operations | ||||
| EBIT | -$45.23 | -$56.4 | -$84.38 | |
| Income tax expense | $2 | $36.66 | -$0.39 | -$15.54 |
| Interest expense | $3.21 | $0.26 | $0.51 | $0.94 |
| Net income | ||||
| Net income | -$28.5 | -$82.16 | -$56.53 | -$69.79 |
| Income (for common shares) | -$82.16 | -$56.53 | -$69.79 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $782.26 | $1024.11 | $720.86 | $886.68 |
| Cost of revenue | $321.67 | $381.55 | $295.47 | $359.15 |
| Gross Profit | $460.59 | $642.56 | $425.39 | $527.53 |
| Operating activities | ||||
| Research & development | $337.74 | $332.33 | $273.21 | $287.89 |
| Selling, general & administrative | $147 | $190.97 | $185.02 | $201.34 |
| Total operating expenses | $484.74 | $523.3 | $458.23 | $489.23 |
| Operating income | -$24.15 | $119.26 | -$32.84 | $38.3 |
| Income from continuing operations | ||||
| EBIT | -$21.02 | $136.57 | $2161.86 | $49.44 |
| Income tax expense | $7.94 | $38.45 | $13.43 | $2.77 |
| Interest expense | $5.55 | $6.72 | $31.03 | $34.14 |
| Net income | ||||
| Net income | -$34.52 | $91.4 | $2117.4 | $12.53 |
| Income (for common shares) | -$34.52 | $91.4 | $2117.4 | $12.53 |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$82.16 | -$56.53 | -$69.79 | |
| Operating activities | ||||
| Depreciation | $6.52 | $6.63 | $6.71 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $15.84 | $13.61 | $11.04 | |
| Total cash flows from operations | $16.13 | -$71.8 | $18.54 | |
| Investing activities | ||||
| Capital expenditures | -$3.53 | -$2.05 | -$3.75 | |
| Investments | $43.14 | $83.54 | $47.26 | |
| Total cash flows from investing | $151.3 | $39.61 | $81.49 | $43.39 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.77 | $0.34 | $6.6 | |
| Net borrowings | -$45 | |||
| Total cash flows from financing | -$51.68 | -$6.4 | -$45.71 | $5.65 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $75.58 | $49.34 | -$36.02 | $67.58 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$34.52 | $91.4 | $2117.4 | $12.53 |
| Operating activities | ||||
| Depreciation | $25.71 | $22.52 | $18.05 | $17.78 |
| Business acquisitions & disposals | -$316.81 | |||
| Stock-based compensation | $48.21 | $60.51 | $56.84 | $60.09 |
| Total cash flows from operations | -$30.35 | $71.81 | -$100.44 | $135.72 |
| Investing activities | ||||
| Capital expenditures | -$22.28 | -$26.52 | -$28.58 | -$20.42 |
| Investments | $492.61 | $267.06 | -$446.93 | -$22.21 |
| Total cash flows from investing | $469.81 | $240.54 | $2271.02 | -$361.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$202.53 | -$871.64 | -$1135.86 | -$1.27 |
| Net borrowings | -$491.16 | -$0.02 | -$140.57 | $220.26 |
| Total cash flows from financing | -$711.87 | -$887.05 | -$1298.67 | $200.87 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$272.41 | -$574.71 | $871.9 | -$24.43 |
News
Fundamentals
| Market cap | $3.62B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 32.34M |
| Revenue | $504.98M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$236.97M |
| Revenue Q/Q | -18.34% |
| Revenue Y/Y | -47.00% |
| P/E ratio | -15.29 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 7.18 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$7.33 |
|---|---|
| ROA | -17.93% |
| ROE | N/A |
| Debt/Equity | 0.19 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.19 |
| Quick ratio | 4.01 |